Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.
about
Use of siRNA molecular beacons to detect and attenuate mycobacterial infection in macrophagesDiscovery of novel MDR-Mycobacterium tuberculosis inhibitor by new FRIGATE computational screenHitting bacteria at the heart of the central dogma: sequence-specific inhibitionThe Delta fbpA mutant derived from Mycobacterium tuberculosis H37Rv has an enhanced susceptibility to intracellular antimicrobial oxidative mechanisms, undergoes limited phagosome maturation and activates macrophages and dendritic cells.Mycobacterium tuberculosis origin of replication and the promoter for immunodominant secreted antigen 85B are the targets of MtrA, the essential response regulatorPeptide nucleic acid antisense oligomer as a therapeutic strategy against bacterial infection: proof of principle using mouse intraperitoneal infectionThe three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.Surface-exposed proteins of pathogenic mycobacteria and the role of cu-zn superoxide dismutase in macrophages and neutrophil survival.Bacterial antisense RNAs: how many are there, and what are they doing?Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.Rational design and rapid screening of antisense oligonucleotides for prokaryotic gene modulation.Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis.Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy.Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.DNA vaccines against mycobacterial diseases.Three consecutive arginines are important for the mycobacterial peptide deformylase enzyme activityInhibition of Mycobacterium tuberculosis glutamine synthetase as a novel antibiotic strategy against tuberculosis: demonstration of efficacy in vivo.Inhalation of recombinant adenovirus expressing granulysin protects mice infected with Mycobacterium tuberculosis.Use of a tetracycline-inducible system for conditional expression in Mycobacterium tuberculosis and Mycobacterium smegmatis.The Mycobacterium tuberculosis Ag85A is a novel diacylglycerol acyltransferase involved in lipid body formation.Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity.
P2860
Q26796753-65712DAE-B5DF-4745-B49B-6F55E027C937Q28478254-95B9B428-7210-49B5-8F70-63FA825C98EDQ28756986-1BA27864-1C59-4AA8-B968-C49AB8CD2541Q33318121-ED759784-9598-4A70-9F70-1214ECB4AF74Q33855102-E68256BC-9F34-44B9-86DF-DE0E2A09BE4AQ33938093-98AC8706-5943-44E7-A84B-EE1927A7507AQ34139044-87018104-DB3E-43CE-A1E0-79E4F25C3797Q34248620-108B5AE0-C5DB-4FB3-88C6-8545C4520B1BQ34537427-2F7E4154-C2D3-4442-BEDC-E0BAD3E71D71Q34628570-F94E2E5C-8285-45A0-A06A-BD436094EEC3Q35130605-C5BF5E31-7C7B-47BC-9423-72953C6C0F39Q35758597-78470EF2-63B0-464C-B2F1-D8C99F18E74EQ36161416-6653728F-6D63-4848-9E7E-7C1ED9537DA1Q36543277-ED4D2B9A-1D05-4657-AE71-152EF0FFAC15Q36895737-8C2547D6-816A-4CCC-9A06-3CB2E169E278Q38289809-24C4A2D0-BDE3-4696-A2D5-A969D81327EAQ39707366-3190D89B-89C5-4135-9269-0B72C7823ABCQ41105185-AB9CE669-DE5C-467B-9A07-D7549BB2611CQ42863645-E2858506-D6ED-4DCE-A31A-31A7680C9C65Q44400006-B0C8B859-BF81-4CE0-8661-C020181AE0DDQ44932638-1FDA2AE6-E4E7-4132-9524-CBE15328DF9D
P2860
Targeting the Mycobacterium tuberculosis 30/32-kDa mycolyl transferase complex as a therapeutic strategy against tuberculosis: Proof of principle by using antisense technology.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
name
Targeting the Mycobacterium tu ...... by using antisense technology.
@ast
Targeting the Mycobacterium tu ...... by using antisense technology.
@en
Targeting the Mycobacterium tu ...... by using antisense technology.
@nl
type
label
Targeting the Mycobacterium tu ...... by using antisense technology.
@ast
Targeting the Mycobacterium tu ...... by using antisense technology.
@en
Targeting the Mycobacterium tu ...... by using antisense technology.
@nl
prefLabel
Targeting the Mycobacterium tu ...... by using antisense technology.
@ast
Targeting the Mycobacterium tu ...... by using antisense technology.
@en
Targeting the Mycobacterium tu ...... by using antisense technology.
@nl
P2093
P2860
P356
P1476
Targeting the Mycobacterium tu ...... by using antisense technology
@en
P2093
Günter Harth
Marcus A Horwitz
Paul C Zamecnik
P2860
P304
15614-15619
P356
10.1073/PNAS.242612299
P407
P577
2002-11-11T00:00:00Z